Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

DOPTELET

AVATROMBOPAG MALEATE

Standard Dose
EQ 20MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DOPTELET is listed in Drugs@FDA under application 210238 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient AVATROMBOPAG MALEATE Form and strength TABLET;ORAL - EQ 20MG BASE Sponsor AKARX INC Submission history Latest submission status date: 2025-07-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview DOPTELET is listed in Drugs@FDA under application 210238 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AVATROMBOPAG MALEATE Form and strength TABLET;ORAL - EQ 20MG BASE Sponsor AKARX INC Submission history Latest submission status date: 2025-07-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.